Liwei Wang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 17

Top Topics

Dna Damage Response

Top Venues

EMBO molecular medicine

Disease markers

This page only lists publications with an associated author ORCID identifier.

Publications

Simin Wang, Yangjie Xiong, Yuxiang Luo, Yanying Shen, Fengrui Zhang, Haoqi Lan, Yuzhi Pang, Xiaofang Wang, Xiaoqi Li, Xufen Zheng, Xiaojing Lu, Xiaoxiao Liu, Yumei Cheng, Tanwen Wu, Yue Dong, Yuan Lu, Jiujie Cui, Xiaona Jia, Sheng Yang, Liwei Wang, Yuexiang Wang
Genome-wide CRISPR screens identify PKMYT1 as a therapeutic target in pancreatic ductal adenocarcinoma. EMBO molecular medicine 16 (5) (2024)
Tommaso Scolaro, Marta Manco, Mathieu Pecqueux, Ricardo Amorim, Rosa Trotta, Heleen H Van Acker, Matthias Van Haele, Niranjan Shirgaonkar, Stefan Naulaerts, Jan Daniluk, Fran Prenen, Chiara Varamo, Donatella Ponti, Ginevra Doglioni, Ana Margarida Ferreira Campos, Juan Fernández-García, Silvia Radenkovic, Pegah Rouhi, Aleksandar Beatovic, Liwei Wang, Yu Wang, Amalia Tzoumpa, Asier Antoranz, Ara Sargsian, Mario Di Matteo, Emanuele Berardi, Jermaine Goveia, Bart Ghesquiere, Tania Roskams, Stefaan J Soenen, Thomas Voets, Bella Manshian, Sarah-Maria Fendt, Peter Carmeliet, Abhishek Dinkarnath Garg, Ramanuj DasGupta, Baki Topal, Massimilliano Mazzone
Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance. Nature cancer 5 (8) (2024)
Simin Wang, Yangjie Xiong, Yuxiang Luo, Yanying Shen, Fengrui Zhang, Haoqi Lan, Yuzhi Pang, Xiaofang Wang, Xiaoqi Li, Xufen Zheng, Xiaojing Lu, Xiaoxiao Liu, Yumei Cheng, Tanwen Wu, Yue Dong, Yuan Lu, Jiujie Cui, Xiaona Jia, Sheng Yang, Liwei Wang, Yuexiang Wang
Genome-wide CRISPR screens identify PKMYT1 as a therapeutic target in pancreatic ductal adenocarcinoma. EMBO molecular medicine 16 (5) (2024)
Simin Wang, Yangjie Xiong, Yuxiang Luo, Yanying Shen, Fengrui Zhang, Haoqi Lan, Yuzhi Pang, Xiaofang Wang, Xiaoqi Li, Xufen Zheng, Xiaojing Lu, Xiaoxiao Liu, Yumei Cheng, Tanwen Wu, Yue Dong, Yuan Lu, Jiujie Cui, Xiaona Jia, Sheng Yang, Liwei Wang, Yuexiang Wang
Genome-wide CRISPR screens identify PKMYT1 as a therapeutic target in pancreatic ductal adenocarcinoma. EMBO molecular medicine (2024)
Simin Wang, Yangjie Xiong, Yuxiang Luo, Yanying Shen, Fengrui Zhang, Haoqi Lan, Yuzhi Pang, Xiaofang Wang, Xiaoqi Li, Xufen Zheng, Xiaojing Lu, Xiaoxiao Liu, Yumei Cheng, Tanwen Wu, Yue Dong, Yuan Lu, Jiujie Cui, Xiaona Jia, Sheng Yang, Liwei Wang, Yuexiang Wang
Genome-wide CRISPR screens identify PKMYT1 as a therapeutic target in pancreatic ductal adenocarcinoma. EMBO molecular medicine 16 (5) (2024)
Tommaso Scolaro, Marta Manco, Mathieu Pecqueux, Ricardo Amorim, Rosa Trotta, Heleen H Van Acker, Matthias Van Haele, Niranjan Shirgaonkar, Stefan Naulaerts, Jan Daniluk, Fran Prenen, Chiara Varamo, Donatella Ponti, Ginevra Doglioni, Ana Margarida Ferreira Campos, Juan Fernández-García, Silvia Radenkovic, Pegah Rouhi, Aleksandar Beatovic, Liwei Wang, Yu Wang, Amalia Tzoumpa, Asier Antoranz, Ara Sargsian, Mario Di Matteo, Emanuele Berardi, Jermaine Goveia, Bart Ghesquiere, Tania Roskams, Stefaan J Soenen, Thomas Voets, Bella Manshian, Sarah-Maria Fendt, Peter Carmeliet, Abhishek Dinkarnath Garg, Ramanuj DasGupta, Baki Topal, Massimilliano Mazzone
Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance. Nature cancer 5 (8) (2024)
Simin Wang, Yangjie Xiong, Yuxiang Luo, Yanying Shen, Fengrui Zhang, Haoqi Lan, Yuzhi Pang, Xiaofang Wang, Xiaoqi Li, Xufen Zheng, Xiaojing Lu, Xiaoxiao Liu, Yumei Cheng, Tanwen Wu, Yue Dong, Yuan Lu, Jiujie Cui, Xiaona Jia, Sheng Yang, Liwei Wang, Yuexiang Wang
Genome-wide CRISPR screens identify PKMYT1 as a therapeutic target in pancreatic ductal adenocarcinoma. EMBO molecular medicine 16 (5) (2024)
Jiujie Cui, Shukui Qin, Yuhong Zhou, Shuang Zhang, Xiaofeng Sun, Mingjun Zhang, Jiu-Wei Cui, Weijia Fang, Kangsheng Gu, Zhihua Li, Jufeng Wang, Xiaobing Chen, Jun Yao, Jun Zhou, Gang Wang, Yuxian Bai, Juxiang Xiao, Wensheng Qiu, Bangmao Wang, Tao Xia, Chunyue Wang, Li Kong, Jiajun Yin, Tao Zhang, Xionghu Shen, Deliang Fu, Chuntao Gao, Huan Wang, Quanren Wang, Liwei Wang
Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or metastatic pancreatic ductal adenocarcinoma following prior gemcitabine-based therapy (PAN-HEROIC-1): a phase 3 trial. Signal transduction and targeted therapy 9 (1) (2024)
Tommaso Scolaro, Marta Manco, Mathieu Pecqueux, Ricardo Amorim, Rosa Trotta, Heleen H Van Acker, Matthias Van Haele, Niranjan Shirgaonkar, Stefan Naulaerts, Jan Daniluk, Fran Prenen, Chiara Varamo, Donatella Ponti, Ginevra Doglioni, Ana Margarida Ferreira Campos, Juan Fernández-García, Silvia Radenkovic, Pegah Rouhi, Aleksandar Beatovic, Liwei Wang, Yu Wang, Amalia Tzoumpa, Asier Antoranz, Ara Sargsian, Mario Di Matteo, Emanuele Berardi, Jermaine Goveia, Bart Ghesquiere, Tania Roskams, Stefaan J Soenen, Thomas Voets, Bella Manshian, Sarah-Maria Fendt, Peter Carmeliet, Abhishek Dinkarnath Garg, Ramanuj DasGupta, Baki Topal, Massimilliano Mazzone
Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance. Nature cancer (2024)
Simin Wang, Yangjie Xiong, Yuxiang Luo, Yanying Shen, Fengrui Zhang, Haoqi Lan, Yuzhi Pang, Xiaofang Wang, Xiaoqi Li, Xufen Zheng, Xiaojing Lu, Xiaoxiao Liu, Yumei Cheng, Tanwen Wu, Yue Dong, Yuan Lu, Jiujie Cui, Xiaona Jia, Sheng Yang, Liwei Wang, Yuexiang Wang
Genome-wide CRISPR screens identify PKMYT1 as a therapeutic target in pancreatic ductal adenocarcinoma. EMBO molecular medicine 16 (5) (2024)
Tommaso Scolaro, Marta Manco, Mathieu Pecqueux, Ricardo Amorim, Rosa Trotta, Heleen H Van Acker, Matthias Van Haele, Niranjan Shirgaonkar, Stefan Naulaerts, Jan Daniluk, Fran Prenen, Chiara Varamo, Donatella Ponti, Ginevra Doglioni, Ana Margarida Ferreira Campos, Juan Fernández-García, Silvia Radenkovic, Pegah Rouhi, Aleksandar Beatovic, Liwei Wang, Yu Wang, Amalia Tzoumpa, Asier Antoranz, Ara Sargsian, Mario Di Matteo, Emanuele Berardi, Jermaine Goveia, Bart Ghesquiere, Tania Roskams, Stefaan J Soenen, Thomas Voets, Bella Manshian, Sarah-Maria Fendt, Peter Carmeliet, Abhishek Dinkarnath Garg, Ramanuj DasGupta, Baki Topal, Massimilliano Mazzone
Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance. Nature cancer 5 (8) (2024)
Tommaso Scolaro, Marta Manco, Mathieu Pecqueux, Ricardo Amorim, Rosa Trotta, Heleen H Van Acker, Matthias Van Haele, Niranjan Shirgaonkar, Stefan Naulaerts, Jan Daniluk, Fran Prenen, Chiara Varamo, Donatella Ponti, Ginevra Doglioni, Ana Margarida Ferreira Campos, Juan Fernández-García, Silvia Radenkovic, Pegah Rouhi, Aleksandar Beatovic, Liwei Wang, Yu Wang, Amalia Tzoumpa, Asier Antoranz, Ara Sargsian, Mario Di Matteo, Emanuele Berardi, Jermaine Goveia, Bart Ghesquiere, Tania Roskams, Stefaan J Soenen, Thomas Voets, Bella Manshian, Sarah-Maria Fendt, Peter Carmeliet, Abhishek Dinkarnath Garg, Ramanuj DasGupta, Baki Topal, Massimilliano Mazzone
Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance. Nature cancer (2024)
Shengbai Xue, Kangjie Shen, Kexuan Wang, Weiyu Ge, Tiebo Mao, Shumin Li, Xiaofei Zhang, Haiyan Xu, Yongchao Wang, Jiayu Yao, Ming Yue, Jingyu Ma, Yanling Wang, Daiyuan Shentu, Jiujie Cui, Liwei Wang
Prediction of Survival and Tumor Microenvironment Infiltration Based on Pyroptosis-Related lncRNAs in Pancreatic Cancer. Disease markers 2022 (2022)
Shengbai Xue, Kangjie Shen, Kexuan Wang, Weiyu Ge, Tiebo Mao, Shumin Li, Xiaofei Zhang, Haiyan Xu, Yongchao Wang, Jiayu Yao, Ming Yue, Jingyu Ma, Yanling Wang, Daiyuan Shentu, Jiujie Cui, Liwei Wang
Prediction of Survival and Tumor Microenvironment Infiltration Based on Pyroptosis-Related lncRNAs in Pancreatic Cancer. Disease markers 2022 (2022)
Xiao-Lin Lin, Ting Han, Qing Xia, Jiujie Cui, Meng Zhuo, Yiyi Liang, Wenyu Su, Lisha Wang, Liwei Wang, Zebing Liu, Xiu-Ying Xiao
CHPF promotes gastric cancer tumorigenesis through the activation of E2F1. Cell death & disease 12 (10) (2021)
Xiaofei Zhang, Tiebo Mao, Bei Zhang, Haiyan Xu, Jiujie Cui, Feng Jiao, Dongqin Chen, Yu Wang, Jiong Hu, Qing Xia, Shumin Li, Ming Yue, Jingyu Ma, Jiayu Yao, Yongchao Wang, Xiao Zhang, Shiqing Chen, Yuezong Bai, Yuexiang Wang, Xuebin Zhang, Qiang Liu, Yongwei Sun, Deliang Fu, Ying-Bin Liu, Lei Xiong, Liwei Wang
Characterization of DNA damage response deficiency in pancreatic cancer patients from China. Cancer communications (London, England) (2021)
Qing Xia, Jing Jia, Chupeng Hu, Jinying Lu, Jiajin Li, Haiyan Xu, Jianchen Fang, Dongju Feng, Liwei Wang, Yun Chen
Tumor-associated macrophages promote PD-L1 expression in tumor cells by regulating PKM2 nuclear translocation in pancreatic ductal adenocarcinoma. Oncogene (2021)